Eurasian Journal of Medical and Natural Sciences 2-jild 11-son (2022) · 111–116-betlar

MODERN DRUGS AFFECTING LIPID METABOLISM IN ISCHEMIC HEART DISEASE

Karimov, Izzatulla

DOI: 10.5281/zenodo.7180381 · Manbada o'qish →

Annotatsiya

Stable ischaemic heart disease is a frequent and very heterogeneous condition. Drug therapy is important, in these patients, for improving their prognosis and controlling their symptoms. The typical clinical manifestation of obstructive coronary disease is angina pectoris. This symptom can be improved by various classes of compounds, namely beta-blockers (BBs), calcium antagonist, and nitrates. More recently, ranolazine and ivabradine have been introduced. All these drugs have been proven to reduce significantly angina. On the other hand, there are no evidences supporting improvement in prognosis, besides for the use of BBs, in patients with previous myocardial infarction (MI) or systolic dysfunction. Besides drugs for symptoms control, these patients also receive antiplatelet drugs, specifically aspirin, and lipid lowering compounds such as statins.

Stable angina, Ischaemic heart disease, modern treatments, Lipid metabolism disorder

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.